查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球肌腱板损伤治疗市场：未来按方式(关节镜检查,肩关节置换术,肌腱修復),物理治疗(支架,冷却按压),药物治疗(抗炎剂,注射剂),骨科预测至2026
市场调查报告书
商品编码
1070359

全球肌腱板损伤治疗市场：未来按方式(关节镜检查,肩关节置换术,肌腱修復),物理治疗(支架,冷却按压),药物治疗(抗炎剂,注射剂),骨科预测至2026

Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026
出版日期: | 出版商: MarketsandMarkets | 英文 117 Pages | 订单完成后即时交付

价格
简介目录

全球肩袖损伤治疗市场预计将从 2021 年的 8.99 亿美元增长到 2026 年的 12.44 亿美元。

此外，预测期间的复合年增长率预计为 4.7%。市场的主要驱动力是运动相关肩关节疾病的增加、关节镜手术设备的技术进步、患有骨关节炎的老年人口的增加以及旨在推出先进关节镜治疗设备的公司，这包括对部分的兴趣增加

按类型，手术或根治性治疗是最大的部分。按地区划分，预计亚太地区在预测期内将以最高的复合年增长率增长。

本报告分析了全球肌腱板损伤治疗市场，分析了市场的基本结构和最新情况、主要市场促进/制约因素、市场趋势前景、按类型(按方式)和按地区。我们正在调查详细的趋势、市场竞争状况、主要公司的概况等。

目录

第一章介绍

第二章调查方法

第 3 章执行摘要

第 4 章市场概述

  • 简介
  • 市场动态
    • 行业增长机会
    • 燃烧问题和挑战
    • 冠状病毒感染 (COVID-19)：独特趋势
  • 监管状态
  • 兑换场景
  • 价格趋势分析
  • 临床研究管道
  • 专利分析

第 5 章肩袖损伤治疗市场：按类型

  • 简介
  • 手术/根治性治疗
    • 常规/开放手术
    • 关节镜检查(肌腱修復)
  • 物理治疗、姑息治疗
    • 矫形支具(矫形器)
    • 冷压疗法
  • 药品、预防性治疗
    • 消炎镇痛
    • 注入
  • 骨科

第 6 章肩袖损伤治疗市场：按地区划分

  • 简介
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第7章竞争态势

  • 概览
    • 大公司的战略
  • 在每个治疗区域运营的主要公司列表
    • 产品组合/开发管道
    • 主要战略/成功战略
  • 衝突场景
    • 肩袖损伤治疗市场：产品发布和监管批准
    • 肩袖损伤治疗市场：资本市场
    • 肩袖损伤治疗市场：其他发展
    • 竞争领导力图谱
  • 肩袖损伤治疗市场主要公司的足迹分析
    • 肩袖损伤治疗市场的顶级公司：治疗产品和区域足迹分析

第 8 章公司简介

  • 主要公司
    • STRYKER CORPORATION
    • JOHNSON & JOHNSON
    • SMITH & NEPHEW
    • ARTHREX
    • ZIMMER BIOMET
    • INTEGRA LIFESCIENCES
    • LIMACORPORATE S.P.A
    • DJO GLOBAL, INC.
    • EVOLUTIS
    • GROUP FH ORTHO
    • CONMED CORPORATION
    • 3S ORTHO
    • ANIKA THERAPEUTICS, INC. (PARCUS MEDICAL)
    • GPC MEDICAL LTD.
    • BREG, INC.

第9章 附录

简介目录
Product Code: MD 8076

The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period". The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices, increase in the aging population with osteoarthritis, strong focus of players towards launch of highly advanced arthroscopic treatment devices. On the other hand, a dearth of skilled professionals, a high surgical treatment failure rate, and its high cost are major challenges faced by market players providing rotator cuff injury treatment products.

The COVID-19 pandemic is an unprecedented crisis that has significantly strained healthcare providers, healthcare infrastructure, and healthcare systems worldwide. The COVID-19 pandemic had a remarkable change in several aspects of medical practice. Elective surgeries, including orthopedic surgery, were canceled worldwide, allowing hospitals to accommodate more COVID-19 patients and completely focus on reducing the possible risk of infection among healthcare workers. According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID-19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. The rotator cuff injury treatment market was also impacted due to restrictions on the organized temporary closure of surgical centers, hospital access restriction for non-essential care, limited access to clinics, implementation of social distancing measures, nationwide lockdowns, and the slowdown of in-patient flow and referrals.

"The surgical or curative treatment to capture the largest share in rotator cuff injury treatment market, by type during the forecast period."

The surgical treatment segment is expected to hold the largest share of rotator cuff injury treatment market, during the forecast period. This is attributable to the high adoption due to the increasing prevalence of rotator cuff injuries majorly among sportspersons, rising awareness activities by major market players across key countries, and the availability of medical reimbursements for surgical treatment of rotator cuff rupture. Additionally, the increase in the preference of shoulder arthroscopy for the treatment rotator cuff tear among surgeons and the growing awareness about the benefits associated with arothrocopic repair such as lower risk of complications, quick recovery, low rate of post surgical infections are likely to play a significant role in propelling the growth of the segment.

"The Asia Pacific market to grow at the highest CAGR during the forecast period."

The rotator cuff injury treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. significant increase in its geriatric and patient population for orthopedic diseases, growing adoption of orthopedic bracing products in developing nations of Asia Pacific, growing presence of rotator cuff injury treatment devices and drugs manufacturers in the country, increase in the initiatives by the government to promote sports, and growing adoption of new surgical devices for rotator cuff tears launched by local manufacturers are likely to support the growth of the market in the region.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
  • By Designation: C-level: 26%, D-level: 30%, and Others: 44%
  • By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).

Research Coverage

This report studies the global rotator cuff injury treatment market based on the treatment type, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global in rotator cuff injury treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MAJOR MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA SOURCES
      • 2.1.1.1 Secondary Data Sources
    • 2.1.2 PRIMARY DATA SOURCES
    • FIGURE 2 BREAKDOWN OF PRIMARIES: ROTATOR CUFF RUPTURE TREATMENT MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 TREATMENT USAGE-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION BASED ON TREATMENT UTILIZATION METHODOLOGY
    • FIGURE 5 MARKET SIZE ESTIMATION BASED ON REVENUE MAPPING METHODOLOGY
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

  • 3.1 ROTATOR CUFF RUPTURE TREATMENT MARKET
    • FIGURE 7 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 8 MARKET OPPORTUNITY IN ROTATOR CUFF RUPTURE TREATMENT MARKET DURING 2020-2026 (USD MN)

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 INDUSTRY GROWTH OPPORTUNITIES
      • 4.2.1.1 Rising number of sports-related shoulder injuries
    • FIGURE 9 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US PER 1000 INHABITANATS (2020)
      • 4.2.1.2 Technological advancements in rotator cuff rupture devices
      • 4.2.1.3 Growing public-private funding grants and educational awareness initiatives
      • 4.2.1.4 Increasing risk of osteoarthritis in the geriatric population
    • TABLE 1 NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION (2019 VS. 2050)
      • 4.2.1.5 Growing developments in orthobiologics
    • 4.2.2 BURNING ISSUES AND CHALLENGES
      • 4.2.2.1 High costs associated with arthroscopic surgical procedures
      • 4.2.2.2 High failure rates of rotator cuff surgical treatment
      • 4.2.2.3 Shortage of trained orthopedic professionals
    • 4.2.3 COVID-19 SPECIFIC TRENDS
  • 4.3 REGULATORY LANDSCAPE
    • 4.3.1 NORTH AMERICA
      • 4.3.1.1 US
    • TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 4.3.1.2 Canada
    • TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 10 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (CMDR)
    • 4.3.2 EUROPE
    • FIGURE 11 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
    • 4.3.3 ASIA PACIFIC
      • 4.3.3.1 India
      • 4.3.3.2 Japan
    • TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 4.3.3.3 China
    • TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 4.3.3.4 India
  • 4.4 REIMBURSEMENT SCENARIO
    • TABLE 7 REIMBURSEMENT CODES FOR PHYSICIAN SERVICES (AS OF 2020)
    • TABLE 8 REIMBURSEMENT CODES FOR OUTPATIENT SERVICES (AS OF 2020)
  • 4.5 PRICING TREND ANALYSIS
    • TABLE 9 AVERAGE PRICE OF ROTATOR CUFF TREATMENT INSTRUMENTS, BY REGION COUNTRY, 2020 (USD)
  • 4.6 CLINICAL RESEARCH PIPELINE
    • 4.6.1 ROTATOR CUFF REPAIR TREATMENT
    • TABLE 10 ROTATOR CUFF REPAIR: INDICATIVE LIST OF ONGOING CLINICAL TRIALS (AS OF 2021)
  • 4.7 PATENT ANALYSIS
    • FIGURE 12 TOP 10 PATENT APPLICANTS FOR ROTATOR CUFF REPAIR (JANUARY 2011 TO OCTOBER 2021)
    • FIGURE 13 NUMBER OF GRANTED PATENTS AND PATENT APPLICATIONS (JANUARY 2011 TO OCTOBER 2021)
    • FIGURE 14 PATENT DOCUMENTS FOR ROTATOR CUFF REPAIR, BY LEGAL STATUS (JANUARY 2011 TO OCTOBER 2021)
    • FIGURE 15 REGIONAL ANALYSIS OF PATENTS GRANTED FOR ROTATOR CUFF REPAIR, 2020

5 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE

  • 5.1 INTRODUCTION
    • TABLE 11 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 5.2 SURGICAL OR CURATIVE TREATMENT
    • 5.2.1 TRADITIONAL/OPEN SURGERIES
      • 5.2.1.1 Shoulder replacement surgeries
      • 5.2.1.2 Open tendon repair/transfer
    • 5.2.2 ARTHROSCOPY (TENDON REPAIR)
    • TABLE 12 ARTHOSCOPY TREATMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 5.3 PHYSIOTHERAPY OR PALLIATIVE TREATMENT
    • TABLE 13 PHYSIOTHERAPY TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 5.3.1 ORTHOPEDIC BRACES
    • TABLE 14 ORTHOPEDIC BRACES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 5.3.2 COLD COMPRESSION THERAPY
    • TABLE 15 COLD COMPRESSION THERAPY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 5.4 PHARMACEUTICAL DRUGS OR PREVENTIVE TREATMENT
    • TABLE 16 PHARMACEUTICAL DRUGS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 5.4.1 ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS
    • TABLE 17 ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS MARKET, 2019-2026 (USD MILLION)
    • 5.4.2 INJECTIONS
    • TABLE 18 INJECTIONS MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 5.5 ORTHOBIOLOGICS
    • TABLE 19 ORTHOBIOLOGICS MARKET, BY TYPE, 2019-2026 (USD MILLION)

6 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION

  • 6.1 INTRODUCTION
    • TABLE 20 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.2 NORTH AMERICA
    • TABLE 21 NORTH AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.3 EUROPE
    • TABLE 22 EUROPE ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.4 ASIA PACIFIC
    • TABLE 23 ASIA PACIFIC ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.5 LATIN AMERICA
    • TABLE 24 LATIN AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.6 MIDDLE EAST & AFRICA
    • TABLE 25 MIDDLE EAST & AFRICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)

7 COMPETITIVE LANDSCAPE

  • 7.1 OVERVIEW
    • 7.1.1 KEY PLAYER STRATEGIES
  • 7.2 LIST OF KEY PLAYERS OPERATING IN EACH TREATMENT SPACE
    • 7.2.1 PRODUCT PORTFOLIO/DEVELOPMENT PIPELINE
    • 7.2.2 KEY STRATEGIES/RIGHT TO WIN
  • 7.3 COMPETITIVE SCENARIO
    • 7.3.1 ROTATOR CUFF RUPTURE TREATMENT MARKET: PRODUCT LAUNCHES & REGULATORY APPROVALS
    • TABLE 26 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS, JANUARY 2018-OCTOBER 2021
    • 7.3.2 ROTATOR CUFF RUPTURE TREATMENT MARKET: DEALS
    • TABLE 27 KEY DEALS, JANUARY 2018-OCTOBER 2021
    • 7.3.3 ROTATOR CUFF RUPTURE TREATMENT MARKET: OTHER DEVELOPMENTS
    • TABLE 28 OTHER KEY DEVELOPMENTS, JANUARY 2018-OCTOBER 2021
    • 7.3.4 COMPETITIVE LEADERSHIP MAPPING
      • 7.3.4.1 Stars
      • 7.3.4.2 Pervasive players
      • 7.3.4.3 Emerging leaders
      • 7.3.4.4 Participants
    • FIGURE 16 ROTATOR CUFF RUPTURE TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 7.4 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET
    • 7.4.1 TREATMENT PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET
    • TABLE 29 TREATMENT PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 30 REGIONAL FOOTPRINT OF COMPANIES

8 COMPANY PROFILES

  • 8.1 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, and MnM view)**
    • 8.1.1 STRYKER CORPORATION
    • TABLE 31 STRYKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 17 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
    • 8.1.2 JOHNSON & JOHNSON
    • TABLE 32 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 18 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
    • 8.1.3 SMITH & NEPHEW
    • TABLE 33 SMITH & NEPHEW: BUSINESS OVERVIEW
    • FIGURE 19 SMITH & NEPHEW: COMPANY SNAPSHOT (2020)
    • 8.1.4 ARTHREX
    • TABLE 34 ARTHREX: BUSINESS OVERVIEW
    • 8.1.5 ZIMMER BIOMET
    • TABLE 35 ZIMMER BIOMET: BUSINESS OVERVIEW
    • FIGURE 20 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
    • 8.1.6 INTEGRA LIFESCIENCES
    • TABLE 36 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
    • FIGURE 21 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
    • 8.1.7 LIMACORPORATE S.P.A
    • TABLE 37 LIMACORPORATE: BUSINESS OVERVIEW
    • FIGURE 22 LIMACORPORATE: COMPANY SNAPSHOT (2020)
    • 8.1.8 DJO GLOBAL, INC.
    • TABLE 38 DJO GLOBAL, INC.: BUSINESS OVERVIEW
    • FIGURE 23 DJO GLOBAL, INC.: COMPANY SNAPSHOT (2020)
    • 8.1.9 EVOLUTIS
    • TABLE 39 EVOLUTIS: BUSINESS OVERVIEW
    • 8.1.10 GROUP FH ORTHO
    • TABLE 40 GROUP FH ORTHO: BUSINESS OVERVIEW
    • 8.1.11 CONMED CORPORATION
    • TABLE 41 CONMED CORPORATION: BUSINESS OVERVIEW
    • FIGURE 24 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
    • 8.1.12 3S ORTHO
    • TABLE 42 3S ORTHO: BUSINESS OVERVIEW
    • 8.1.13 ANIKA THERAPEUTICS, INC. (PARCUS MEDICAL)
    • TABLE 43 ANIKA THERAPEUTICS: BUSINESS OVERVIEW
    • FIGURE 25 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2020)
    • 8.1.14 GPC MEDICAL LTD.
    • TABLE 44 GPC MEDICAL LTD.: BUSINESS OVERVIEW
    • 8.1.15 BREG, INC.
    • TABLE 45 BREG, INC.: BUSINESS OVERVIEW
  • *Details on Business overview, Products offered, Recent developments, and MnM view not be captured in case of unlisted companies.

9 APPENDIX

  • 9.1 DISCUSSION GUIDE
  • 9.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 9.3 RELATED REPORTS
  • 9.4 AVAILABLE CUSTOMIZATIONS